ABOUT LIQUID TADALAFIL: Tadalafil is a selective inhibitor of the enzyme phosphodiesterase type 5
(PDE5), identified in the smooth muscle cells of various tissues, such as the corpus cavernosum, vascular and visceral smooth muscle, skeletal muscle, platelets, kidney, lung, cerebellum, prostate, urethra, and bladder. It is one of a family of 11 PDEs that degrade cyclic guanosine monophosphate or cyclic adenosine monophosphate, or both.
Scientific data gathered during animal research, suggest that inhibition of PDE-5 may improve signs and symptoms of Erectile Dysfunction, Benign Prostatic Hyperplasia, and other Lower Urinary Tract Symptoms. Tadalafil liquid functions through the relaxation of smooth muscle and the reduction in endothelial cell proliferation in the prostate, bladder, and pelvic vasculature. Consequently, increasing perfusion of the lower urinary tract.
PDE-5 catalyzes the breakdown of the potent smooth muscle-relaxing agent, cyclic guanosine monophosphate (cGMP). The inhibition of PDE-5 increases cGMP levels reducing intracellular calcium and induces vasodilation.
BUY TADALAFIL LIQUID Today from LOTI LABS!
We offer the highest grade and purity of liquid tadalafil for sale at an affordable price in the USA. For shipping details, please click here.
For best results in your research, buy liquid tadalafil of the highest quality from LOTI LABS.
Use our products for only research/laboratory purposes. Violation is strictly forbidden. Please read our Terms and Conditions.
Anyone using products sold by LOTI LABS for any purpose other than research/laboratory use will be added to our no-sell list.
For more information on Tadalafil please visit Wikipedia.
| Weight | 0.1875 lbs |
| Appearance | Viscous cloudy liquid |
| Stability | Room Temperature out of direct sunlight |
| Molar Mass | 389.4g |
| CAS Number | ----------- |
| Container | 30ml Bottle |
| Molecular Formula | C22H19N3 O4 |
| Concentration | 30mg per ML |
| Terms | This product is sold for research/laboratory usage only. No other uses are permited. |